Please assess the completion status of the following clinical trial:

Trial Title: Use of Myo-inositol as Adjuvant Therapy in Patients With Polycystic Ovary Syndrome (PCOS) in Vitro Fertilization (IVF)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients PCOS (Rotterdam ESHRE / ASRM criteria)~Combination of at least two of the following three criteria:~* Cycle disorder~* Clinical hyperandrogenism and / or biological~* Account antral follicles\> 24~* Age ≤ 18 ≤ 38 years~* BMI \<35 kg / m²~* Able to understand the protocol and signed informed consent~Exclusion Criteria:~* Patients not having the Rotterdam criteria~* Patients\> 38 years and / or BMI\> 35 kg / m²~* Woman enjoying a measure of legal protection~* Hypersensitivity to any component of the Inofolic (myo-inositol, soy, folic acid, glycerol, gelatin, coloring E171)~* Participation in another interventional biomedical research with treatment administered may disrupt ovarian stimulation

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 38 Years
- Healthy Volunteers: f

Study Arms:
- Inofolic® (Type: EXPERIMENTAL): standard ovarian stimulation and Inofolic®
- Gonadotropins;Folic Acid (Type: ACTIVE_COMPARATOR): standard ovarian stimulation without Inofolic®

Based on this trial design, predict the completion outcome and termination type (if applicable).